Clinical Trial Details

USOR 18020

A Phase 1/2a Study of BMS-986253 in Combination With Nivolumab in Advanced Cancers


Request Additional Trial Information
Full Trial Details:

Condition: Advanced Cancer
Study Type: Interventional
Phase: I
Study Start Date: 07/19/2018
Study Completion Date: 11/2023

The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab in patients with advanced cancers.


NCT Number
Principal Investigator(s)
John Wallmark, MD
Bristol-Myers Squibb
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female


  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.